Pediatric dyslipidemia: recommendations for clinical management

Area of Science:

• Pediatric Cardiology
• Preventive Cardiology
• Public Health

Background:

• Atherosclerosis, a leading cause of cardiovascular disease (CVD), originates in childhood.
• Subclinical atherosclerosis and associated risk factors are detectable in children, tracking into adulthood.
• Early identification of at-risk children enables preventive interventions against future CVD events.

Purpose of the Study:

• To raise awareness about the prevalence of childhood atherosclerosis and its implications for future cardiovascular health.
• To highlight the importance of early screening and management of CVD risk factors in pediatric populations.
• To advocate for the implementation of evidence-based guidelines for CVD prevention in children and young adults.

Main Methods:

• Review of autopsy data and imaging studies documenting childhood atherosclerosis.
• Analysis of longitudinal studies on the tracking of cardiovascular risk factors from childhood to adulthood.
• Examination of the 2011 National Heart, Lung, and Blood Institute Expert Panel guidelines for CVD risk assessment in youth.

Main Results:

• Childhood atherosclerosis is linked to measurable risk factors that persist into adulthood, elevating future CVD risk.
• The 2011 guidelines recommend universal CVD risk screening for children aged 9-11 and 17-21.
• Early therapeutic interventions, including lifestyle changes and lipid-lowering medications, are beneficial.

Conclusions:

• Preventing cardiovascular disease is possible through early detection and management of risk factors in childhood.
• Universal screening and timely intervention are crucial for mitigating the long-term burden of atherosclerosis.
• Awareness among healthcare providers, policymakers, and the public is essential for effective pediatric CVD prevention strategies.